single-fraction SBRT

RADIATION2 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, Odense University Hospital

Conditions

Breast CancerColorectal CancerNSCLCNodal Oligorecurrent Prostate CancerOligo-metastatic Prostate CarcinomaOligometastatic CancerOligometastatic DiseaseProstate Cancer

Unknown Phase

OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)

RecruitingNCT06462963

European Organisation for Research and Treatment of Cancer - EORTCBreast Cancer, Colorectal Cancer, NSCLC +2

Start: 2025-04-15End: 2029-02-15Target: 302Updated: 2025-08-01

MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)

Not yet recruitingNCT07635108

Odense University HospitalNodal Oligorecurrent Prostate Cancer, Oligometastatic Cancer, Oligo-metastatic Prostate Carcinoma +1

Start: 2026-06-01End: 2035-09-01Target: 48Updated: 2026-06-15